Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by standudu
Group name EquipeCTCS
Item Type Journal Article
Title Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
Creator Guiu et al.
Author Séverine Guiu
Author Anita Wolfer
Author William Jacot
Author Pierre Fumoleau
Author Gilles Romieu
Author Franck Bonnetain
Author Maryse Fiche
Abstract The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special type' (former invasive ductal carcinoma, representing 60-70% of all breast cancers), 30 special types, of which invasive lobular carcinoma (ILC) is the most common (5-15%). We review the literature on (i) the specificity and heterogeneity of ILC biology as documented by various analytical techniques, including the results of molecular testing for risk of recurrence; (ii) the impact of lobular histology on prediction of prognosis and effect of systemic therapies in patients. Though it is generally admitted that ILC has a better prognosis than IDC, is endocrine responsive, and responds poorly to chemotherapy, currently available data do not unanimously support these assumptions. This review demonstrates some lack of specific data and a need for improving clinical research design to allow oncologists to make informed systemic therapy decisions in patients with ILC. Importantly, future studies should compare various endpoints in ILC breast cancer patients among the group of hormonosensitive breast cancer.
Publication Critical Reviews in Oncology/Hematology
Volume 92
Issue 3
Pages 235-257
Date Dec 2014
Journal Abbr Crit. Rev. Oncol. Hematol.
Language eng
DOI 10.1016/j.critrevonc.2014.07.003
ISSN 1879-0461
Short Title Invasive lobular breast cancer and its variants
Library Catalog PubMed
Extra PMID: 25129506
Tags Breast Neoplasms, Carcinoma, Lobular, Female, Genetic Testing, Genomics, Humans, Invasive breast cancer, Invasive lobular carcinoma, Luminal breast cancer, Neoplasm Grading, Neoplasm Invasiveness, Pleomorphic invasive lobular carcinoma, Predictive factor, Prognosis, review, Treatment Outcome, Tubulo-lobular carcinoma
Date Added 2019/05/31 - 16:04:04
Date Modified 2019/05/31 - 16:04:21
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés